Overview
Amal Ezzaiyani is a Pediatric Nephrologist and a Pediatrics provider in Brooklyn, New York. Dr. Ezzaiyani is rated as an Experienced provider by MediFind in the treatment of Minimal Change Disease. Her top areas of expertise are Nephrotic Syndrome, Minimal Change Disease, Autosomal Dominant Tubulointerstitial Kidney Disease, and Nephronophthisis. Dr. Ezzaiyani is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
Locations
Howard Trachtman is a Pediatric Nephrologist and a Pediatrics provider in New York, New York. Dr. Trachtman is rated as an Elite provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Focal Segmental Glomerulosclerosis, Minimal Change Disease, Glomerulonephritis, Nephrotic Syndrome, and Kidney Transplant.
Cohen Children's Northwell Health Physician Partners Pediatric Specialists At New Hyde Park
Christine Sethna is a Pediatric Nephrologist in Lake Success, New York. Dr. Sethna is rated as a Distinguished provider by MediFind in the treatment of Minimal Change Disease. Her top areas of expertise are Nephrotic Syndrome, Minimal Change Disease, Focal Segmental Glomerulosclerosis, Hypertension, and Kidney Transplant.
Pediatric Nephrology
Frederick J. Kaskel, MD, PhD, is involved in basic and clinical investigations into the mechanisms of the major kidney disorders in pediatrics. He is particularly interested in the physiology and pathophysiology of normal and abnormal development and function of the kidneys throughout the critical periods of growth and maturation extending into adolescence and young adulthood. He is actively involved in a clinical trial funded by the National Institutes of Health (NIH) to find the most efficacious therapy for focal segmental glomerulosclerosis, one of the major causes of progressive glomerular disease, while investigating the molecular etiologies for its expression. Another NIH-supported study involves chronic kidney disease in children and how it affects their growth and neurocognitive development, and the risk factors for cardiovascular disease and renal progression. Dr. Kaskel is rated as a Distinguished provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change Disease, Metabolic Acidosis, and Kidney Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Nephrotic SyndromeDr. Ezzaiyani isAdvanced. Learn about Nephrotic Syndrome.
- Experienced
- Alport SyndromeDr. Ezzaiyani isExperienced. Learn about Alport Syndrome.
- Autosomal Dominant Tubulointerstitial Kidney Disease
- Cardiofaciocutaneous SyndromeDr. Ezzaiyani isExperienced. Learn about Cardiofaciocutaneous Syndrome.
- GlomerulonephritisDr. Ezzaiyani isExperienced. Learn about Glomerulonephritis.
- Minimal Change DiseaseDr. Ezzaiyani isExperienced. Learn about Minimal Change Disease.
- NephronophthisisDr. Ezzaiyani isExperienced. Learn about Nephronophthisis.

